SURE: Web Posters from SURE 2004

Arf and Arl Protein Expression and Purification Using Auto-Induction of BL21 Bacteria
Corey Monteith, Brad Bowzard, Punya Ranjan, and Richard A. Kahn
Emory School of Medicine, Department of Biochemistry, Atlanta, GA

Abstract

Expression of mammalian proteins in bacteria is a useful method to create the amounts of these proteins needed for biochemical analyses. A commonly used method includes the use of IPTG to induce protein expression in BL21cells carrying pET-based vectors. However, plasmids are unstable in BL21 cells grown in LB medium and cell density must be monitored regularly for optimal induction in log phase growth. Studier and colleagues have developed new media and methods that eliminate these limitations upon the use of BL21 cells for protein expression. The new system uses auto-induction of the desired protein at high cell density to also obtain substantially higher levels of protein expression. This method was tested with cultures of BL21 cells that were transformed with plasmids directing expression of five Arf proteins and 16 Arf-like (Arl) or Sar proteins. We found that the use of P-0.5G minimal medium allowed BL21 cells to much more stably maintain the pET vectors than did LB medium. In addition, with only a few exceptions (Arf4 and Arf5) this newer system of protein expression allowed much higher levels of protein to be expressed in bacteria. Fully 15 of the 21 proteins tested expressed to high enough levels that they were readily observed in Coomassie blue stained samples of bacterial lysates. As most of the Arl proteins have never been purified or analysed, we began the process of purifying as many of these as possible, to allow biochemical analyses of these regulatory proteins for the first time. We adopted methods previously determined for Arf purification (Randazzo et al., 19952) from bacteria to generate preparations of Arl2, Arl3, Arl5, Arl5B, Arl8, and Arl11. From one liter of bacterial culture we typically obtained in excess of 50 mg purified proteins in each case. Thus, these new media and system for bacterial protein production appear to significantly enhance our ability to obtain large amounts of purified Arfs and Arls.

Introduction

The Arf family is a group of proteins that are about 21 kDaltons in size. They are members of the Ras superfamily of GTP-binding proteins used in cell signaling and regulation. There are two divisions of the Arf family, based on function, Arf and Arf-like (Arl) proteins, with a total of 21 Arf family members in human cells. The most common method of generating large amounts (mgs) of protein for biochemical and structural studies is the pET vector and BL21 cell growth in LB medium, as first developed by Studier, et al (Studier and Moffatt, 19863; Studier et al., 19904). While very useful for many years, this system suffers from variability in protein expression, likely caused by the need to use freshly transformed bacteria in LB medium as plasmids are unstable, and the need to monitor cell density carefully to get optimal protein expression. Studier and colleagues have now developed a newer method of protein expression in bacteria involving media that create more stable transformants as well as producing higher protein expression, without the need for induction. E. coli are transformed with pET-based plasmids as in the earlier method, but cultures are then grown in a medium (P-0.5G) in which expression is suppressed and plasmids are very stable. A small sample of this culture can be used to inoculate medium (ZYP-5052) that promotes auto-induction at high cell density. Expression is much higher and proteins are anecdotal evidence suggests proteins may remain more soluble.

Methods and Materials

I. Media Preparation
LB medium was prepared according to standard practice. The new media included P-0.5G, in which BL21 cells were grown for long- and short-term storage and used to inoculate large scale cultures for protein expression, and ZYP-5052, used for large scale protein expressions. P-0.5G consisted of 1 mM MgSO4, .5% glucose, .025 M (NH4)2SO4, .05 M KH2PO4, .05 M Na2HPO4, 100 ??g/mL methionine, 50 ??g/mL ampicillin, 5 ??M Fe, 2 ??M Ca, 1 ??M Mn, 1 ??M Zn, .2 ??M Co, .2 ??M Cu, .2 ??M Ni, .2 ??M Mo, .2 ??M Se, and .2 ??M H3BO3. The final concentrations of reagents in ZYP-5052 were 1 mM MgSO4, .5% glycerol, .05% glucose, .2% ? -lactose, .025 M (NH4)2SO4, .05 M KH2PO4, .05 M Na2HPO4, 50 ??g/mL ampicillin, 50 ??M Fe, 20 ??M Ca, 10 ??M Mn, 10 ??M Zn, 2 ??M Co, 2 ??M Cu, 2 ??M Ni, 2 ??M Mo, 2 ??M Se, and 2 ??M H3BO3.

II. Transformation
BL21(DE3) cells were transformed with pET-based plasmids made by former Kahn lab member Shana Kerr, that direct expression of each of the 21 human Arf family members. Transformants were plated onto LB+ampicillin plates and grown overnight for selection

III. Culture in P-0.5G
Colonies were picked the next day and used to inoculate liquid growth in P-0.5G medium. After overnight growth, an aliquot of this culture was mixed with 80% glycerol and stored at -80 degrees C. Although not done in our studies these frozen cells can be used to inoculate ZYP-5052 cells directly in the future.

IV. Culture in ZYP-5052 ZYP-5052
(1 L) cultures were inoculated with a ~0.1- 1 mL of a P-0.5G culture and grown overnight at room temperature (RT) and at 37 degrees C. These cultures were tested for expression by resolving bacterial lysates in SDS-PAGE gels and staining with Coomassie blue to visualize proteins.

V. Cell Lysis and Protein Purification
Pellets were resuspended in TM buffer (20 mM Tris-Cl pH 7.5 1 mM MgSO4) and lysed by three passes through a French pressure cell. Soluble proteins were obtained by centrifugation at 100 000xg for one hour and the supernatant was run on a Macro Q column for ion exchange chromatography on an FPLC machine using a linear gradient of 0-1000 mM NaCl. An SDS-PAGE gel was run on fractions chosen from UV readout. Most of the GTPases eluted very early from this column which effectively resolves them from the majority of bacterial proteins.

VI. Concentration and Further Protein Purification
Fractions from the Macro Q column containing the desired protein were pooled and put in a stirred cell concentrator with a PM10 filter. When the volume was ~2-5 ml it was applied onto a Sephacryl S75 column for gel filtration chromatography. Fractions were again analyzed by SDS-PAGE gel to determine which fractions contained the desired protein. These fractions were pooled concentrated and frozen at -80 degrees C for later analyses.

Conclusions and Future Studies

The methods and media developed by Studier, et al are a much faster, easier, more reproducible, and cheaper way of producing proteins on a large scale than the current widely-used method. IPTG is unnecessary, re-transformation of bacteria is unnecessary, and higher expression is achieved. Altogether this is a far superior method of obtaining proteins for study. In the future, nucleotide binding to the new Arls will be studied by members of the Kahn lab. This will include defining under what conditions Arls bind GTP and GDP, if lipids are necessary in binding activity, if there is GTPase activity, whether Arl proteins bind directly to cell membranes as Arf proteins do, and whether Arls are post-translationally modified as Arfs are (N-myristoylated) or Arfrp is (N-acetylated). Mass spectroscopy of these proteins purified from mammalian cells will also be done to learn if there is a group covalently attached to the Arl proteins. Eventually, specificity for binding to Arf GEFs and GAPs will be tested as well. Such studies will teach us a lot about how cells regulate a large number of essential cellular processes, including membrane traffic and the cytoskeleton.

Acknowledgements and Funding Attributions

This work was supported by NIH funding provided to the Kahn lab of Emory School of Medicine, Department of Biochemistry, Atlanta, GA. Acknowledgements go to the members of the Kahn lab for their assistance and expertise.

References
1 Kahn, R. A. (2004). ARF Family GTPases, Vol 1 (Dordrecht, Kluwer Academic Publishers).
2 Randazzo, P. A., Weiss, O., and Kahn, R. A. (1995). Preparation of recombinant ADP-ribosylation factor. Methods Enzymol 257, 128-135.
3 Studier, F. W., and Moffatt, B. A. (1986). Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189, 113-130. 4Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990). Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185, 60-89.

In Plain English

The ability to make a large amount of proteins is important to understanding how they work. This involves transforming bacteria with plasmids, or making them take up a small, circular piece of DNA that contains a sequence that codes for the protein you want to express. A very common yet cumbersome method of making transformants uses a chemical called IPTG, which you can only add at a precise point in bacterial growth. The medium that the bacteria is grown in is a simple mixture called LB. The plasmids are not stable in bacteria grown in this medium, so if you want more bacteria with plasmids in them, you have to transform those bacteria again. Studier labs have developed a new set of media in which plasmids are stable in the bacteria, and in which you don't have to add IPTG. We transformed bacteria with plasmids that contained sequences for expression of proteins called Arf proteins, to discern if this new method worked better than the old one.

Techniques

Bacterial transformation, Plasmid DNA isolation, gel electrophoresis, SDS-PAGE, culturing, centrifugation, protein determination, French press, FPLC (ion exchange chromatography, gel filtration chromatography), spectrophotometry, and liquid scintillation.